Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
University of California, San Francisco
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Jazz Pharmaceuticals
Bayer
Actuate Therapeutics Inc.
Hoffmann-La Roche
Psyence Australia Pty Ltd
Daiichi Sankyo
Boehringer Ingelheim
HealthPartners Institute
OHSU Knight Cancer Institute
Mayo Clinic
Tempus AI
Institut Bergonié
Day One Biopharmaceuticals, Inc.
Apollomics Inc.
Elevation Oncology
Rain Oncology Inc
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Exelixis
Universitair Ziekenhuis Brussel
Charite University, Berlin, Germany
pharmaand GmbH
Hoffmann-La Roche
Endocyte
Northwestern University
Cambridge University Hospitals NHS Foundation Trust
Hoffmann-La Roche
Washington University School of Medicine
Wake Forest University Health Sciences
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)